Runben Biotechnology Co., Ltd. (SHA:603193)
China · Delayed Price · Currency is CNY 21.25
+0.57 (2.76%)
Aug 25, 2026, 3:00 PM CST
Runben Biotechnology Revenue
Runben Biotechnology had revenue of 786.78M CNY in the quarter ending June 30, 2026, with 20.10% growth. This brings the company's revenue in the last twelve months to 1.70B, up 15.95% year-over-year. In the year 2025, Runben Biotechnology had annual revenue of 1.54B with 17.19% growth.
Revenue (ttm)
1.70B
Revenue Growth
+15.95%
P/S Ratio
4.91
Revenue / Employee
1.67M
Employees
1,018
Market Cap
8.37B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.54B | 226.61M | 17.19% |
| Dec 31, 2024 | 1.32B | 285.22M | 27.61% |
| Dec 31, 2023 | 1.03B | 176.87M | 20.66% |
| Dec 31, 2022 | 856.09M | 273.94M | 47.06% |
| Dec 31, 2021 | 582.15M | 139.32M | 31.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.